Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series

被引:1
|
作者
Barker, Victoria E. [1 ,2 ]
Vlachodimitropoulou, Evangelia [1 ,2 ]
O'Brien, Patrick [1 ,2 ]
Iskaros, Joseph [1 ,2 ]
Rosenthal, Adam N. [1 ,2 ,3 ]
机构
[1] Univ Coll London Hosp, Natl Hlth Serv Fdn Trust, London, England
[2] UCL, Univ Coll London Elizabeth Garrett Anderson Inst W, Dept Womens Canc, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
BREAST-CANCER; OVARIAN; RISK; WOMEN;
D O I
10.1097/AOG.0000000000005423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16-68% and 11-30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery.CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11-59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400-1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was -1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure.CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs.
引用
收藏
页码:1500 / 1503
页数:4
相关论文
共 50 条
  • [1] Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?
    Vyarvelska, Iryna
    Rosen, Barry
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 219 - 221
  • [2] Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
    DiSilvestro, Jessica B.
    Haddad, Jessica
    Robison, Katina
    Beffa, Lindsey
    Laprise, Jessica
    Scalia-Wilbur, Jennifer
    Raker, Christina
    Clark, Melissa
    Lokich, Elizabeth
    Hofstatter, Erin
    Dalela, Disha
    Brown, Amy
    Bradford, Leslie
    Toland, Maris
    Stuckey, Ashley
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (07): : 732 - 737
  • [3] Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
    Conduit, Ciara
    Milne, Roger L.
    Friedlander, Michael L.
    Phillips, Kelly-Anne
    CANCER PREVENTION RESEARCH, 2021, 14 (11) : 983 - 993
  • [4] Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
    Rhiem, Kerstin
    Foth, Dolores
    Wappenschmidt, Barbara
    Gevensleben, Heidrun
    Buettner, Reinhard
    Ulrich, Uwe
    Schmutzler, Rita K.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (03) : 623 - 627
  • [5] Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation
    Kotsopoulos, Joanne
    Hall, Elizabeth
    Finch, Amy
    Hu, Hanxian
    Murphy, Joan
    Rosen, Barry
    Narod, Steven A.
    Cheung, Angela M.
    JAMA NETWORK OPEN, 2019, 2 (08)
  • [6] No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
    van Bommel, Majke H. D.
    de Jong, Marieke Arts
    Steenbeek, Miranda P.
    Bots, Michiel L.
    van Westerop, Liselore L. M.
    Hopman, Maria T. E.
    Hoogerbrugge, Nicoline
    de Hullu, Joanne A.
    Maas, Angela H. E. M.
    JOURNAL OF CARDIOLOGY, 2021, 77 (06) : 570 - 575
  • [7] Changes in Bone Density in Carriers of BRCA1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy
    Chan, Leslie N. N.
    Chen, Lee-may
    Goldman, Mindy
    Mak, Julie S. S.
    Bauer, Douglas C. C.
    Boscardin, John
    Schembri, Michael
    Bae-Jump, Victoria
    Friedman, Sue
    Jacoby, Vanessa L. L.
    OBSTETRICS AND GYNECOLOGY, 2023, 142 (01) : 160 - 169
  • [8] Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer
    Chapman, Jocelyn S.
    Roddy, Erika
    Panighetti, Anna
    Hwang, Shelley
    Crawford, Beth
    Powell, Bethan
    Chen, Lee-may
    CLINICAL BREAST CANCER, 2016, 16 (06) : 494 - 499
  • [9] Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection
    Martelli, Gabriele
    Barretta, Francesco
    Vernieri, Claudio
    Folli, Secondo
    Pruneri, Giancarlo
    Segattini, Silvia
    Trapani, Anna
    Carolla, Claudia
    Spatti, Gianbattista
    Miceli, Rosalba
    Ferraris, Cristina
    JAMA SURGERY, 2023, 158 (12) : 1275 - 1284
  • [10] Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
    Maxwell, Kara N.
    Domchek, Susan M.
    CURRENT BREAST CANCER REPORTS, 2012, 4 (03) : 199 - 206